Screener
Organon OGN Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Organon’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 8:46 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029532
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total Liabilities | 12,093 | 12,115 |
| Contingencies (Note 15) | ||
| Organon & Co. Stockholders’ Equity: | ||
| Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 262,649 in 2026 and 260,316 in 2025 | 3 | 3 |
| Additional paid-in capital | 186 | 167 |
| Retained earnings | 1,253 | 1,109 |
| Accumulated other comprehensive loss | (539) | (527) |
| Total Stockholders’ Equity | 903 | 752 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Organon's common stock par value per share?
- Organon (OGN) reported common stock par value per share of $0.01 in Q1 2026.
- How has Organon's common stock par value per share changed year-over-year?
- Organon's common stock par value per share decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Organon's common stock par value per share?
- Over 4 years (2021 to 2025), Organon's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about Organon's common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude